Clinical Trial Update: Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating inhaled fluticasone propionate with salmeterol versus placebo to improve respiratory function in children over six years old after allo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• Salmeterol (salmeterol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Stem Cell Transplant Complications, Respiratory Disease | Phase 3 | Status: TERMINATED